Comparison of Novel PSMA-targeting [177Lu]lu-P17-087 with Its Albumin Binding Derivative [177Lu]lu-P17-088 in Metastatic Castration-Resistant Prostate Cancer Patients: a First-in-human Study
European Journal of Nuclear Medicine and Molecular Imaging（2024）
关键词
Radioligand therapy (RLT),Lu-177,Prostate-specific membrane antigen (PSMA),Metastatic castration-resistant prostate cancer (mCRPC)
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要